COMMUNIQUÉS West-GlobeNewswire

Clearside Biomedical Receives Notification of FDA Acceptance of NDA Filing for XIPERE™ (triamcinolone acetonide ophthalmic suspension) for Suprachoroidal Injection with PDUFA Date Set for October 19, 2019
20/02/2019
ALPHARETTA, Ga., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Medtronic Announces U.S. Commercial Launch of Deep Brain Stimulation for Medically-Refractory Epilepsy
20/02/2019
With Official Launch and First Implant, Several Health Insurers N ow Consider DBS Therapy for Epilepsy a Covered Indication DUBLIN - February 20, 2019 - Medtronic plc (NYSE:MDT) today announced both the U.S. launch of [...]
PotBotics: Bringing Big Data to Medical Cannabis -- CFN Media
20/02/2019
Seattle, Washington, Feb. 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]
BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2018
20/02/2019
Biohit Oyj Financial Statement Release, 20 February 2019 at 9:30 am local time (EET) SUMMARY January-December 2018 Net sales EUR 9.9 million (EUR 9.0 million) Net sales grew by 10.6% compared to 2017 Operative EBITDA [...]
Acarix Year-End Report 2018: Market dynamics favourable for CADScor®System, addressing the challenges of the global healthcare market
20/02/2019
Malmö, February 20, 2019 Acarix Year-End Report 2018: Market dynamics favourable for CADScor®System, addressing the challenges of the global healthcare market "After six months at Acarix, I clearly see our market [...]
Verona Pharma to Announce Financial Results for Full Year ended December 31, 2018 and Provide Clinical Development Update
20/02/2019
LONDON, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Neovacs announces two appointments to its executive committee
20/02/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES TWO APPOINTMENTS TO ITS EXECUTIVE COMMITTEE Vincent Serra, PhD – Chief Scientific Officer Valerie Salentey, Pharm D - Head of Regulatory Affairs Paris [...]
Néovacs annonce deux nominations au sein de son comité exécutif
20/02/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS ANNONCE DEUX NOMINATIONS AU SEIN DE SON COMITÉ EXÉCUTIF Vincent Serra, PhD - Directeur Scientifique (CSO) Valérie Salentey, PharmD - Responsable [...]
Canntab Provides Corporate Update
20/02/2019
Moving into FSD Pharma and FSD Processing License Mackie Research Extension Director Estate Planning Initiative OTCQB under symbol CTABF TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL [...]
Vigil Reports Third Quarter Results
20/02/2019
VICTORIA, British Columbia, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”) (TSX-VEN: VGL) announces the results of operations for the quarter ending December 31, 2018. Developments in the [...]
MacroGenics Announces Date of Fourth Quarter and Full Year 2018 Financial Results Conference Call
20/02/2019
ROCKVILLE, MD, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Chembio Diagnostics to Participate in the BTIG Medical Technology, Life Science and Diagnostic Tools Conference
20/02/2019
MEDFORD, N.Y., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the Company plans to participate in [...]
Management Cease Trade Order Update
20/02/2019
HALIFAX, Nova Scotia, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued [...]
Vical to Discontinue Clinical Development of VL-2397 as it Considers Near Term Strategic Alternatives
19/02/2019
SAN DIEGO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that it has decided to discontinue the Phase 2 clinical trial of VL‑2397 that was initiated in the first quarter of 2018. The [...]
2019 Budget Focuses on Savings for Individuals and Families
19/02/2019
VICTORIA, British Columbia, Feb. 19, 2019 (GLOBE NEWSWIRE) -- The budget presented today by the B.C. government is strongly focused on reducing costs for B.C. families, a move which will be welcomed individually by [...]
REVA Announces Voluntary Suspension of Trading
19/02/2019
SAN DIEGO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that on 20 February 2019 (AEDT), the Australian Securities Exchange issued a market announcement indicating [...]
Nashville Business Leader Acquires Integrative Life Center
19/02/2019
Former Premier Parking CEO, Ryan Chapman, plans to broaden services of Nashville-based behavioral health care provider NASHVILLE, Tenn., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Ryan Chapman, who grew and sold a nationwide [...]
Sienna Senior Living Inc. Reports 2018 Fourth Quarter Financial Results
19/02/2019
MARKHAM, Ontario, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced its financial results for the three months and year ended December 31, 2018. The [...]
Lifeline Biotechnologies, Inc. Updates Current Shareholders and the Public
19/02/2019
Reno, Nevada, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- We are pleased to share current information and developments with our stakeholders and the public, February 19, 2019. Regarding Lifeline’s investment [...]

Pages